Parexel Transforms FSP Model to Outcomes-Driven, AI-Enabled Delivery Structure
- Parexel restructured its functional service provider (FSP) business into an integrated model pairing 8,000+ clinical, data management, biometrics, regulatory, and safety resources under single accountability with ParexelAI technology.
- New model explicitly shifts FSP market away from headcount-based staffing toward outcomes-driven, technology-enabled capacity that scales flexibly with sponsor pipeline demands.
- Appointment of Sanjay Vyas as President of Integrated Solutions signals organizational commitment to reduce handoffs, automate manual workflows, and improve R&D productivity for sponsors navigating complex global development programs.
Operational Impact
Parexel's shift from headcount-based to outcomes-driven FSP delivery with embedded AI automation signals a structural change in how leading CROs are packaging functional capacity, potentially raising sponsor expectations for accountability and integrated technology across the FSP market.
Source: PharmaSource RSS